Resources
Everything we have published, in one place.
225+ peer-reviewed publications and posters since 2013, downloadable reports and dataset documentation, and every company announcement.
Download our latest citations report
Trio publishes new citation reports regularly, containing both new and historical publications sorted by disease state.
Peer-reviewed
Publications and posters
Selected publications · full 225+ list in the citations report
-
Poster
American Academy of Allergy, Asthma, & Immunology/ World Allergy Organizations (AAAAI/WAO) Joint Congress · 2025
Long-Term Prophylaxis for Hereditary Angioedema: Real-World Treatment Patterns in Selected US Allergy Clinics
Huamin Henry Li, Jason Raasch, Marc Riedi, Scott Milligan, Jim Ruggles, Cathy Schnabel, Kathleen F. Villa, Monica McClain
Poster presented at: AAAAI/WAO; 2025 February 28-March 3; San Diego, CA. doi:10.1016/j.jaci.2024.12.744
Allergy & Asthma — Hereditary angioedema (HAE) Read -
Poster
American Academy of Allergy, Asthma, & Immunology/ World Allergy Organizations (AAAAI/WAO) Joint Congress · 2025
Study to Adjudicate Hereditary Angioedema with Normal C1INH Diagnoses in the PINOEER-HAE Database
Maeve O’Connor, Dana Winthrow, Scott Milligan, Vibha Desai, Paul K. Audhya, Marc A. Riedi
Poster presented at: AAAAI/WAO; 2025 February 28-March 3; San Diego, CA. doi:10.1016/j.jaci.2024.12.988
Allergy & Asthma — Hereditary angioedema (HAE) Read -
Abstract
American Academy of Allergy, Asthma, & Immunology/ World Allergy Organizations (AAAAI/WAO) Joint Congress · 2025
The Activated Phosphoinositide 3-kinase Delta Syndrome Characterization and Clinical Outcomes Immunologic Registry (APDS-CHOIR): Early Insights in Immunologic Phenotyping
Kelli W. Williams, Valeria Duran, Andrew Frick, Nicholas L. Hartog, Micholas L. Rider, Brian Hartline
Presentation presented at AAAAI/WAO; 2025 February 28- March 3; San Diego, CA. doi:10.1016/j.jaci.2024.12.564
Rare Disease — Activated PI3K delta syndrome (APDS) Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2023
Barriers to Persisting on Prophylactic Treatment For C1-Esterase Inhibitor Deficient Hereditary Angioedema; Observations from Community Immunology
Jason Raasch, William R. Lumry, Scott C. Milligan, and Marc Riedl
Poster presented at: ISPOR 2023 Conference; 2023 May 7-10; Boston, MA. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2023.03.2053
Allergy & Asthma — Hereditary angioedema (HAE) Read -
Manuscript
Haemophilia the Journal of the World Federation of Hemophilia · 2023
Effects of PK-guided prophylaxis on clinical outcomes and FVIII consumption for patients with moderate to severe Haemophilia A
Young, G, Callaghan, MU, Balasa, V, et al.
Published in Haemophilia the Journal of the World Federation of Hemophilia. August 8, 2023. doi:10.1111/hae.14826
Hematology — Hemophilia A Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2023
Are Biosimilars Equivalent To Originator Molecules In The Real-World? Assessments Of Efficacy, Toxicity, And Tolerability of Infliximabs in Infliximab-Naïve Patients With Rheumatoid Arthritis
Jasvinder A. Singh, Simon Helfgott, Kent Kwas Huston, Nehad Soloman, Andrew Frick, Scott Milligan, Colin Edgerton
Poster presented at: ISPOR 2023 Conference; 2023 May 7-10; Boston, MA. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2023.03.227
Immunology & Rheumatology — Rheumatoid arthritis Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2023
Persistency on Conventional Synthetic DMARDS without Evidence of Rheumatoid Arthritis Control; Identifying Populations That May Benefit from Availability of Lower-Cost TNFi Biosimilars
Frick A, Broestl J, Cox K, Milligan K, Persons D, Milligan S
Poster presented at: ISPOR 2023 Conference; 2023 May 7-10; Boston, MA. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2023.03.2336
Immunology & Rheumatology — Rheumatoid arthritis Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2023
Reuse of Tumor Necrosis Factor Inhibitors for Treatment of Rheumatoid Arthritis despite Discordance with Patient Important Outcomes and Standard Disease Assessments
Frick A, Broestl J, Cox K, Milligan K, Persons D, Milligan S
Poster presented at: ISPOR 2023 Conference; 2023 May 7-10; Boston, MA. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2023.03.092
Immunology & Rheumatology — Rheumatoid arthritis Read -
Manuscript
Lupus Science & Medicine · 2023
Steroid-sparing effect of belimumab: results from a retrospective observational study of real-world data
Karen Worley, Scott Milligan, Bernard Rubin
Journal published in Lupus Science & Medicine 2023 Dec 22;10:e001024. doi:10.1136/lupus-2023-001024
Immunology & Rheumatology — Systemic lupus erythematosus (SLE) Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2023
Towards Better Rheumatoid Arthritis Management by Identification of Potentially Manageable Conditions Observed with Early Discontinuation of Biologic/Targeted Synthetic (b/ts) DMARDs
Christopher Adams, Simon Helfgott, Kent Huston, Andrew Frick, Scott Milligan, Jasvinder A. Singh, Nehad Soloman, Colin C. Edgerton
Poster presented at: ISPOR 2023 Conference; 2023 May 7-10; Boston, MA. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2023.03.136
Immunology & Rheumatology — Rheumatoid arthritis Read -
Manuscript
Pulmonary Circulation Journal · 2023
Characteristics of Patients with Pulmonary Arterial Hypertension from an Innovative, Comprehensive Real-World Patient Data Repository
Harrison W. Farber, Murali M. Chakinala, Michelle Cho, Robert P. Frantz, Andrew Frick, Lisa Lancaster, Scott Milligan, Ronald Oudiz, Sumeet Panjabi, Yuen Tsang, Steven D. Nathan
Pulmonary Circulation 13 (3): e12258. July 06, 2023. doi:10.1002/pul2.12258
Pulmonology — Pulmonary arterial hypertension (PAH) Read -
Poster
American College of Allergy, Asthma & Immunology (ACAAI) · 2022
Attack Location And Severity/Resolution In Patients With Hereditary Angioedema (HAE); Observations From Community Immunology
William R. Lumry, H. Henry Li, Scott C. Milligan, Jason Raasch, and Marc Riedl
Poster presented at: American College of Allergy, Asthma & Immunology- 2022 Annual Scientific Meeting, 2022 Nov 10-14; Louisville, Kentucky. doi:10.1016/j.anai.2022.08.593
Allergy & Asthma — Hereditary angioedema (HAE) Read -
Poster
American College of Allergy, Asthma & Immunology (ACAAI) · 2022
Development Of The Patient-Important Outcomes National Data Repository (PIONEER) For Hereditary Angioedema (HAE)
William R. Lumry, Joshua Jacobs, H. Henry Li, Scott C. Milligan, Maeve E. O’Connor, Jason Raasch, and Marc Riedl
Poster presented at: American College of Allergy, Asthma & Immunology- 2022 Annual Scientific Meeting, 2022 Nov 10-14; Louisville, Kentucky. doi:10.1016/j.anai.2022.08.591
Allergy & Asthma — Hereditary angioedema (HAE) Read -
Manuscript
Expert Review of Hematology · 2022
Real-World Study of Rurioctocog Alfa Pegol and Emicizumab in US Clinical Practice Among Patients with Hemophilia A
Shawn X. Sun, Andrew Frick, Vinod Balasa, and Jonathan C. Roberts
Published in: Expert Review of Hematology- Online Access: August 2022. doi:10.1080/17474086.2022.2112171
Hematology — Hemophilia A Read -
Manuscript
The American Journal of GASTROENTEROLOGY · 2022
The Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease
Joana Vieira Barbosa, MD, MSc, Scott Milligan, PhD, Andrew Frick, MSc, Jeremy Broestl, BSc, Zobair Younossi, MD, MPH, Nezam H. Afdhal, MD, and Michelle Lai, MD, MPH
Published in: The American Journal of GASTROENTEROLOGY: Online January 18, 2022. doi:10.14309/ajg.0000000000001606
Hepatology — NASH / NAFLD Read -
Poster
American Thoracic Society (ATS) · 2022
Development of a Comprehensive, Integrated Patient Data Repository of US Pulmonary Hypertension (PH) Patients to Assess the Impact of Clinical Care on Patient Outcomes
H.W. Farber, S. Milligan, S. Panjabi, Y. Tsang, K. Bettencourt, and M. Cho
Poster presented at: ATS 2022 May 13-18. doi:10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A3997
Pulmonology — Pulmonary hypertension (PH) Read -
Poster
HIV Glasgow · 2022
Characteristics of Heavily Treatment Experienced (HTE) People with HIV (PWH) in US Clinical Practice
Joseph J Eron, Megan S Dunbar, Janna Radtchenko, Joshua Gruber, Gregory Huhn, Grace A McComsey, Lauren Temme, and Richard A. Elion
Poster presented at: HIV Glasgow 2022. 2022 October 23-26; Published in Journal of the International AIDS Society and Glasgow site. Abstract P092. doi:10.1002/jia2.26009
Virology — HIV Read -
Manuscript
Hepatology Communications · 2022
First-Line Therapies for Hepatitis B in the United States: A 3-year Prospective and Multicenter Real-World Study after Approval of Tenofovir Alafenamide
Calvin Q. Pan, Nezam H. Afdhal, Victor Ankoma-Sey, Ho Bae, Michael P. Curry, Douglas Dieterich, Lynn Frazier, Andrew Frick, Hie-Won Hann, W. Ray Kim, Paul Kwo, Scott Milligan, Myron J. Tong, and K. Rajender Reddy
Published in: Hepatology Communications: Online April 21, 2022. doi:10.1002/hep4.1964
Virology — Hepatitis B (HBV) Read -
Manuscript
Viruses · 2022
Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders
Heiner Wedemeyer, Vito Di Marco, Montserrat Garcia-Retortillo, Elisabetta Teti, Chris Fraser, Luis Enrique Morano Amado, Sergio Rodriguez-Tajes, Silvia Acosta-Lopez, Joss O’Loan, Michele Milella, Maria Buti, Maria Fernanda Guerra-Veloz, Alnoor Ramji, Mary Fenech, Alexandra Martins, Sergio M. Borgia, Kim Vanstraelen, Michael Mertens, Candido Hernandez, Ianna Ntalla, Heribert Ramroth, and Scott Milligan
Published in: Viruses- Online Access: November 2022. doi:10.3390/v14112493
Virology — Hepatitis C (HCV) Read -
Poster
HIV Glasgow · 2022
Prescription Adherence and Persistence on Oral Pre-exposure Prophylaxis (PrEP) Among Prep-Naive (PN) Individuals After FTC/TAF Approval in the United States (US)
Richard A. Elion, Joshua Gruber, Janna Radtchenko, Megan Dunbar, Kenneth H. Mayer, Gregory Huhn, Karam Mounzer, and Anthony Mills
Poster presented at: HIV Glasgow 2022. 2022 October 23-26; Published in Journal of the International AIDS Society and Glasgow. Abstract P009. doi:10.1002/jia2.26009
Virology — HIV Read -
Poster
American Society of Hematology (ASH) · 2021
A Retrospective Descriptive Study on the Effectiveness and Usage of Emicizumab and Antihemophilic Factor (recombinant), Fc Fusion Protein in Patients with Hemophilia A in the US
Alex Cockerham, Amanda Wilson, Andrew Frick, and Pronabesh Dasmahapatra
Poster presented at: 63rd American Society of Hematology, 2021 December 11-14; Atlanta, Georgia. doi:10.1182/blood-2021-148325
Hematology — Hemophilia A Read -
Poster
Academy of Managed Care Pharmacy (AMCP) · 2021
A Retrospective Study of Rurioctocog Alfa Pegol and Emicizumab Wastage, Consumption, and Costs in US Clinical Practice Among Patients with Hemophilia A
Shawn X. Sun, Andrew Frick
Journal of Managed Care + Specialty Pharmacy 2021 Apr; 27(4-a Suppl): S47-D17 Poster presented at: AMCP Managed Care and Specialty Pharmacy Annual Meeting, 2021 Apr 12-16 and published in Journal of Managed Care + Specialty Pharmacy. doi:10.18553/jmcp.2021.27.4-a.s1
Hematology — Hemophilia A Read -
Poster
European Association for Haemophilia and Allied Disorders (EAHAD) · 2021
A Retrospective Study of the Impact of Switching Patients with Haemophilia A to Rurioctocog Alfa Pegol or Emicizumab in US Practice
Shawn X. Sun, Andrew Frick
ePoster presented at: European Association for Haemophilia and Allied Disorders and published in the Wiley Online Library online; 2021 February 3-5. Abstract ABS039. doi:10.1111/hae.14236
Hematology — Hemophilia A Read -
Manuscript
Hepatology Communications · 2021
Fibrosis-4 Index as an Independent Predictor of Mortality and Liver-Related Outcomes in NAFLD
Joana Vieira Barbosa, Scott Milligan, Andrew Frick, Jeremy Broestl, Zobair Younossi, Nezam H. Afdhal, and Michelle Lai
Published in: Hepatology Communications: Online December 30, 2021. doi:10.1002/hep4.1841
Hepatology — NASH / NAFLD Read -
Poster
The American Association for the Study of Liver Diseases (AASLD) · 2021
The Impact of Race on NAFLD Outcomes in US Clinical Practice
Scott B. Minchenberg, Joana Vieira Barbosa, Scott Milligan, Andrew Frick, Nezam H. Afdhal, and Michelle Lai
Poster presented at: The Liver Meeting. 72nd Annual Meeting of the American Association for the Study of Liver Diseases; 2021 Nov 12-15 VIRTUAL. doi:10.1002/hep.32188
Hepatology — NASH / NAFLD Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2021
Disparities in Targeted Immune Modulating (TIM) Treatment for Elderly Compared to Younger Patients with Psoriatic Arthritis (PSA)
Jasvinder Singh, Andrew Frick, Simon Helfgott, Kent Kwas Huston, Nehad Soloman, John Tesser, and Colin Edgerton
ePoster presented at: Virtual ISPOR 2021 Conference. 2021 May 17-20. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2021.04.1154
Immunology & Rheumatology — Psoriatic arthritis Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2021
Experience with Apremilast in Treatment of Psoriatic Arthritis in US Clinical Practice; Assessments from Trio Health and the American Rheumatology Network (ARN)
Colin Edgerton, Andrew Frick, Simon Helfgott, Ken Kwas Huston, Jasvinder Singh, and Nehad Soloman
ePoster presented at: Virtual ISPOR 2021 Conference. 2021 May 17-20. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2021.04.1152
Immunology & Rheumatology — Psoriatic arthritis Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2021
Management of Gout after Pegloticase; Observations of US Clinical Practice from Trio Health and the American Rheumatology Network (ARN)
Nehad Soloman, Mona Amin, Simon Helfgott, Alexander Hu, Kent Kwas Huston, Jordan Leonard, Kelsey Milligan, Scott Milligan, Jasvinder Singh, John Tesser, and Colin Edgerton
ISPOR Presentations Database ePoster presented at: Virtual ISPOR 2021 Conference. 2021 May 17-20. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2021.04.682
Immunology & Rheumatology — Gout Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2021
Management of Gout with Pegloticase; Real-World Utilization and Outcomes from Trio Health and the American Rheumatology Network (ARN)
Nehad Soloman, Mona Amin, Kimmi Cox, Simon Helfgott, Alexander Hu, Kent Kwas Huston, Jordan Leonard, Scott Milligan, Jasvinder Singh, John Tesser, and Colin Edgerton
ISPOR Presentations Database ePoster presented at: Virtual ISPOR 2021 Conference. 2021 May 17-20. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2021.04.681
Immunology & Rheumatology — Gout Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2021
Outcomes with Infliximab and Its Biosimilars in Patients with Rheumatoid Arthritis (RA): Real-World Experience in the US
Simon Helfgott, MD, Janna Radtchenko, MBA, Nehad Soloman, MD, Kent Kwas Huston, MD, Jasvinder Singh, MD, MPH, and Colin Edgerton, MD
ISPOR Presentations Database ePoster presented at: Virtual ISPOR 2021 Conference. 2021 May 17-20. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2021.04.075
Immunology & Rheumatology — Rheumatoid arthritis Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2021
Real-World Utilization of Janus Kinase Inhibitors (JAKs) and Biologics in Patients with Rheumatoid Arthritis (RA)
Jasvinder A. Singh, MD, MPH, Janna Radtchenko, MBA, Nehad Soloman, MD, Kwas Huston, MD, Simon M. Helfgott, MD, and Colin C. Edgerton, MD
ISPOR Presentations Database ePoster presented at: Virtual ISPOR 2021 Conference. 2021 May 17-20. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2021.04.678
Immunology & Rheumatology — Rheumatoid arthritis Read -
Poster
Academy of Managed Care Pharmacy (AMCP) · 2021
Real-World Utilization of Janus Kinase Inhibitors (JAKs) and Biologics in Patients with Rheumatoid Arthritis (RA)
Janna Radtchenko, Jasvinder A. Singh, MD, MPH, Nehad Soloman, MD, Kwas Huston, MD, Simon M. Helfgott, MD, and Colin C. Edgerton, MD
Journal of Managed Care + Specialty Pharmacy 2021 Apr; 27(4-a Suppl): S103-M9 ePoster presented at: AMCP Managed Care and Specialty Pharmacy Annual Meeting, 2021 Apr 12-16 and published in Journal of Managed Care + Specialty Pharmacy. doi:10.18553/jmcp.2021.27.4-a.s1
Immunology & Rheumatology — Rheumatoid arthritis Read -
Poster
CHEST Annual Meeting · 2021
Care and Characteristics of Patients with Pulmonary Arterial Hypertension (PAH) in US Clinical Practice
Adaani E. Frost, MD, Murali M. Chakinala, MD, FCCP, Robert P. Frantz, MD, Lisa H. Lancaster, MD, FCCP, Steven D. Nathan, MBBCh, FCCP, Ronald J. Oudiz, MD, FCCP, Sumeet Panjabi, PhD, Scott Milligan, PhD, and Harrison W. Farber, MD
ePoster presented at: Virtual CHEST 2021 Conference. 2021 October 17-20. doi:10.1016/j.chest.2021.07.1999
Pulmonology — Pulmonary arterial hypertension (PAH) Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2021
Comorbid Burden and Survival Risk Metrics of Pulmonary Hypertension (PH) Patients in US-Clinical Care: Real-World Assessments from the TRIO Health PH Registry
Murali Chakinala, Deepali Rane, Ronald Oudiz, Adaani Frost, Robert Frantz, Steven Nathan, and Harrison Farber
ISPOR Presentations Database ePoster presented at: Virtual ISPOR 2021 Conference. 2021 May 17-20. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2021.04.344
Pulmonology — Pulmonary hypertension (PH) Read -
Poster
American Thoracic Society (ATS) · 2021
Comorbid Burden and Survival Risk Metrics of Pulmonary Hypertension (PH) Patients in US-Clinical Care: Real-World Assessments from the TRIO Health PH Registry
Murali Chakinala, Deepali Rane, Ronald Oudiz, Adaani Frost, Robert Frantz, Steven Nathan, and Harrison Farber
American Journal of Respiratory and Critical Care Medicine 2021; 203:A1594 ePoster presented at: ATS 2021 May 14-19. doi:10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A1594
Pulmonology — Pulmonary hypertension (PH) Read -
Poster
CHEST Annual Meeting · 2021
Comparison of Idiopathic Versus Connective Tissue Disease-Associated Pulmonary Arterial Hypertension (PAH) Groups in US Clinical Practice
Ronald J. Oudiz, MD, FCCP, Murali M. Chakinala, MD, FCCP, Robert P. Frantz, MD, Adaani E. Frost, MD, Lisa H. Lancaster, MD, FCCP, Steven D. Nathan, MBBCh, FCCP, Sumeet Panjabi, PhD, Andrew Frick, MS, and Harrison W. Farber, MD
ePoster presented at: Virtual CHEST 2021 Conference. 2021 October 17-20. doi:10.1016/j.chest.2021.07.2006
Pulmonology — Pulmonary arterial hypertension (PAH) Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2021
Real-World Clinical Characteristics of 112 Patients with Interstitial Lung Disease (ILD); Update from the Trio Health ILD Registry
Frantz RP, Rane D, Nathan SD, Lancaster L, Frost AE, Chakinala MM, Oudiz RJ, and Farber HW
ISPOR Presentations Database ePoster presented at: Virtual ISPOR 2021 Conference. 2021 May 17-20. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2021.04.1099
Pulmonology — Interstitial lung disease (ILD) Read -
Poster
CHEST Annual Meeting · 2021
Transthoracic Echocardiogram (ECHO) and Right Heart Catheterization (RHC) as Disease Management Tools for Patients with PAH in US Clinical Practice
Murali M. Chakinala, MD, FCCP, Robert P. Frantz, MD, Lisa H. Lancaster, MD, FCCP, Steven D. Nathan, MBBCh, FCCP, Ronald J. Oudiz, MD, FCCP, Sumeet Panjabi, PhD, Nicole Wick, and Harrison W. Farber, MD
ePoster presented at: Virtual CHEST 2021 Conference. 2021 October 17-20. doi:10.1016/j.chest.2021.07.2023
Pulmonology — Pulmonary arterial hypertension (PAH) Read -
Manuscript
Journal of Managed Care + Specialty Pharmacy · 2021
Prevalence of Drug-Drug Interactions with Pangenotypic Direct-Acting Antivirals for Hepatitis C and Real-World Care Management in the United States: A Retrospective Observational Study
Michael P Curry, MD, Steven L Flamm, MD, Scott Milligan, PhD, Naoky Tsai, MD, Nicole Wick, AS, Zobair Younossi, MD, and Nezam H Afdhal, MD
Published in: Journal of Managed Care + Specialty Pharmacy: June. doi:10.18553/jmcp.2021.20550
Virology — Hepatitis C (HCV) Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2021
Understanding Real-World Utilization of Pre-Exposure Prophylaxis (PrEP): Data from Trio Health HIV Research Network
Janna Radtchenko, MBA, and Rick Elion, MD
ePoster presented at: Virtual ISPOR 2021 Conference. 2021 May 17-20. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2021.04.1268
Virology — HIV Read -
Manuscript
Journal of Managed Care & Specialty Pharmacy (JMCP) · 2020
A Retrospective, Observational Study using Specialty Pharmacy Data of Rurioctocog Alfa Pegol Use in the United States
Louis Aledort, MD, Scott Milligan, PhD, Maureen Watt, MSc, and Jason Booth, MPH
J Manag Care Spec Pharam, 2020 Apr;26(4):492-503. Published in: Journal of Managed Care & Specialty Pharmacy (JMCP): April. doi:10.18553/jmcp.2020.26.4.492
Hematology — Hemophilia A Read -
Poster
Digestive Disease Week (DDW) · 2020
Association of FIB4 Score with Disease Progression in Real-World Populations Diagnosed with NAFLD/NASH or at Risk of NASH in US Clinical Practice
Michelle Lai, Jeremy Broestl, Andrew Frick, Richard Haubrich, Bruce Koch, Scott Milligan, Macky Natha, Zobair Younossi, and Nezam Afdhal
Poster presented at: Digestive Disease Week. 2020 May 2-5; Chicago, IL (Cancelled). doi:10.1016/S0016-5085(20)34210-4
Hepatology — NASH / NAFLD Read -
Oral Presentation
Digestive Disease Week (DDW) · 2020
Association of FIB4 Score with Major Cardiovascular Events (MACE) in Real-World Populations Diagnosed with NASH or NAFLD in US Clinical Practice
Michelle Lai, Jeremy Broestl, Andrew Frick, Richard Haubrich, Bruce Koch, Scott Milligan, Macky Natha, Zobair Younossi, and Nezam Afdhal
Oral presented online at: Digestive Disease Week. 2020 May 2-5; Chicago, IL (Cancelled). doi:10.1016/S0016-5085(20)33833-6
Hepatology — NASH / NAFLD Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2020
Evaluation of Liver Outcomes Relative to Use of GLP-1 Receptor Agonists (GLP1A) and/or SGLT-2 Inhibitors (SGLT2I) in Real-World Populations Diagnosed with Type II Diabetes (T2DM) and NASH/NAFLD or at Risk of Nash
Michelle Lai, Andrew Frick, Kavita Juneja, Bruce Koch, Scott Milligan, Macky Natha, Janna Radtchenko, Zobair Younossi, and Nezam Afdhal
Poster presented at: Virtual ISPOR 2020 Conference. 2020 May 15-20; Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2020.04.365
Hepatology — NASH / NAFLD Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2020
Lean and Obese Patients with Non-Alcoholic Steatohepatitis (NASH) / Non-Alcoholic Fatty Liver Disease (NALFD); Comparisons of Populations and Disease Progression
Michelle Lai, Andrew Frick, Richard Haubrich, Bruce Koch, Scott Milligan, Macky Natha, Janna Radtchenko, Zobair Younossi, and Nezam Afdhal
Poster presented at: Virtual ISPOR 2020 Conference. 2020 May 15-20; Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2020.04.363
Hepatology — NASH / NAFLD Read -
Poster
Digestive Disease Week (DDW) · 2020
Use of GLP-1 Receptor Agonists (GLP1a) and/or SGLT-2 Inhibitors (SGLT2i) in Populations with NASH or at Risk of NASH in US Clinical Practice
Michelle Lai, Jeremy Broestl, Kavita Juneja, Scott Milligan, Janna Radtchenko, Zobair Younossi, and Nezam Afdhal
Poster presented at: Digestive Disease Week. 2020 May 2-5; Chicago, IL (Cancelled). doi:10.1016/S0016-5085(20)34283-9
Hepatology — NASH / NAFLD Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2020
Outpatient Costs in Rheumatoid Arthritis (RA) Patients With VS Without Comorbidities
Edgerton CC, Radtchenko J, and Holers VM
Value in Health. 2020; 23 (suppl 1): S214 Poster presented at: Virtual ISPOR 2020 Conference. 2020 May 15-20. doi:10.1016/j.jval.2020.04.691
Immunology & Rheumatology — Rheumatoid arthritis Read -
Poster
American Thoracic Society (ATS) · 2020
A Platform to Combine Clinical, Prescription, And Dispensing Data to Better Inform Idiopathic Pulmonary Fibrosis Care; The Trio Registry
Steven Nathan, MD, Murali Chakinala, MD, Robert Frantz, MD, Adaani Frost, MD, Lisa Lancaster, MD, Kelsey Milligan, Scott Milligan, PhD, Ronald Oudiz, MD, and Harrison Farber, MD
American Journal of Respiratory and Critical Care Medicine 2020; 201:A1519 Poster presented at: ATS 2020 May 15-20; Philadelphia, PA (Cancelled). doi:10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A1519
Pulmonology — Idiopathic pulmonary fibrosis (IPF) Read -
Poster
American Thoracic Society (ATS) · 2020
The Trio Pulmonary Arterial Hypertension Registry; A Platform Combining EMR Clinical Measures with Pharmacy Prescription and Dispensing Data
Steven Nathan, MD, Harrison Farber, MD, Murali Chakinala, MD, Robert Frantz, MD, Adaani Frost, MD, Scott Milligan, PhD, and Ronald Oudiz, MD
American Journal of Respiratory and Critical Care Medicine 2020; 201:A6593 Poster presented at: ATS 2020 May 15-20; Philadelphia, PA (Cancelled). doi:10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A6593
Pulmonology — Pulmonary arterial hypertension (PAH) Read -
Manuscript
Advances in Therapy · 2020
Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve, Compensated Cirrhotic Patients with Chronic Hepatitis C Infection
Steven L. Flamm, Jens Kort, Steven E. Marx, John Strezewski, Douglas E. Dylla, Bruce Bacon, Michael P. Curry, Naoky Tsai, and Nicole Wick
Published in: Advances in Therapy: April 11, 2020. doi:10.1007/s12325-020-01301-5
Virology — Hepatitis C (HCV) Read -
Manuscript
Liver International · 2020
Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Simple, Effective HCV Treatment: Analysis of 5552 Patients from 12 Cohorts
Alessandra Mangia, Scott Milligan, Mandana Khalili, Stefano Fagiuoli, Stephen D. Shafran, Fabrice Carrat, Denis Ouzan, George Papatheodoridis, Alnoor Ramji, Sergio M. Borgia, Heiner Wedemeyer, Ruggero Losappio, Francisco Perez-Hernandez, Nicole Wick, Robert S. Brown Jr, Pietro Lampertico, Karen Doucette, Ioanna Ntalla, Heribert Ramroth, Michael Mertens, Kim Vanstraelen, and Juan Turnes
Published in: Liver International: May 25, 2020. doi:10.1111/liv.14537
Virology — Hepatitis C (HCV) Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2020
Hepatitis B Treatment Patterns in US Clinical Care Following Tenofovir Alafenamide (TAF) Approval
Dr. Michael P. Curry, Dr. Ho S Bae, Dr. Douglas T Dieterich, Dr. Victor AnkomaSey, Dr. K Rajender Reddy, MD, FAASLD, Prof. Calvin Q. Pan, Dr. Hie-Won L Hann, Dr. Myron J Tong, Dr. W. Ray Kim, MD, MBA, FAASLD9, Dr. Paul Y Kwo, MD, Mrs. Lynn Frazier, Ms. Kimmi Cox, Dr. Scott Milligan, and Nezam H Afdhal
Poster presented at: VIRTUAL ISPOR 2020 May 15-20; Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2020.04.484
Virology — Hepatitis B (HBV) Read -
Poster
HIV Glasgow · 2020
Impact of Adherence on Viral Suppression with Bictegravir and Dolutegravir (DTG)- Containing Triple Therapy in Clinical Practice
Paul E. Sax, Keri N. Althoff, Joseph J. Eron, Janna Radtchenko, Helena Diaz-Cuervo, Karam Mounzer, Moti Ramgopal, Steven Santiago, and Richard A. Elion
Poster presented at: HIV Glasgow VIRTUAL. 2020 October 5-8; Published in Journal of the International AIDS Society and Glasgow site. Abstract P029. doi:10.1002/jia.2.25616
Virology — HIV Read -
Manuscript
Journal of Hepatology · 2020
Real-World Effectiveness and Safety of Glecaprevir/Pibrentasvir for the Treatment of Patients with Chronic HCV Infection: A Meta-Analysis
Pietro Lampertico, Jose A. Carrion, Michael Curry, Juan Turnes, Markus Cornberg, Francesco Negro, Ashley Brown, Marcello Persico, Nicole Wick, Ariel Porcalla, Andreas Pangerl, Eric Crown, Lois Larsen, Yao Yu, Heiner Wedemeyer
Published in: Journal of Hepatology: February 12, 2020. doi:10.1016/j.jhep.2020.01.025
Virology — Hepatitis C (HCV) Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2020
Real-World Effectiveness of Direct-Acting Antivirals (DAA) in Young Adult (18-25) and Elderly (80+) Populations with Hepatitis C (HCV)
Naoky Tsai, Bruce Bacon, Michael Curry, Steven Flamm, Andrew Frick, Scott Milligan, Janna Radtchenko, Zobair Younossi, and Nezam Afdhal
Poster presented at: Virtual ISPOR 2020 May 15-20; Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2020.04.483
Virology — Hepatitis C (HCV) Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2020
Real-World Effectiveness of Hepatitis C Virus (HCV) Treatment with Direct-Acting Antivirals (DAA) in Populations with Fatty Liver/Non-Alcoholic Steatohepatitis (FL/NASH), Decompensated Cirrhosis (DCC), Hepatocellular Carcinoma (HCC), and/or Post Liver Transplant (PTX)
Zobair Younossi, Bruce Bacon, Michael Curry, Steven Flamm, Andrew Frick, Scott Milligan, Janna Radtchenko, Naoky Tsai, and Nezam Afdhal
Poster presented at: Virtual ISPOR 2020 May 15-20; Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2020.04.478
Virology — Hepatitis C (HCV) Read -
Manuscript
PLOS ONE · 2020
Real-World Efficacy of Direct Acting Antiviral Therapies in Patients with HIV/HCV
Sonia Vibhakar Patel, Dushyantha T. Jayaweera, Keri N. Althoff, Joseph J. Eron, Janna Radtchenko, Anthony Mills, Graeme Moyle, Steven Santiago, Paul E. Sax, Jason Gillman, Karam Mounzer, Richard A. Elion, and Gregory D. Huhn
Published in: PLOS ONE: February 13, 2020. doi:10.1371/journal.pone.0228847
Virology — HIV/HCV co-infection Read -
Poster
International Society on Thrombosis and Haemostasis (ISTH) · 2019
A Retrospective, Observational Study using Specialty Pharmacy data of Rurioctocog Alfa Pegol Use in the United States
Maureen Watt and Scott Milligan
Res Pract Thromb Haemost. 2019; 3 (Suppl 1): PB0702 Poster presented at: International Society on Thrombosis and Haemostasis Meeting, 2019 July 6-10; Melbourne, Australia. doi:10.1002/rth2.12229
Hematology — Hemophilia A Read -
Poster
American Society of Hematology (ASH) · 2019
Real-world, Age-Stratified FVIII Consumption and Bleed Outcomes Before and After Switching to Rurioctocog Alfa Pegol in a Retrospective, Observational Study Using US Specialty Pharmacy Data
Maureen Watt, Scott Milligan
Blood (2019) 134(Supplement_1): 2411 Poster presented at: 61st American Society of Hematology, 2019 December 7-10; Orlando, Florida. doi:10.1182/blood-2019-124101
Hematology — Hemophilia A Read -
Abstract
American Society of Hematology (ASH) · 2019
Clinical Practice Utilization and Outcomes with Rasburicase Vs Allopurinol for Patients at High Risk of Tumor Lysis Syndrome
Janna Radtchenko, Daniel Lyons, Yvonne Barnes, Scott Milligan, and Edward Drea
Blood 134(Supplement_1): 2203-2203 Abstract accepted at 61st American Society of Hematology, 2019 December 7-10; Orlando, Florida. doi:10.1182/blood-2019-124319
Oncology — Tumor lysis syndrome Read -
Poster
Annual Meeting of the American Society of Clinical Oncology (ASCO) · 2019
Quality of Life (QOL) and Tumor Location in Patients with Desmoid Tumors; Data From The Desmoid Tumor Research Foundation (DTRF) Natural History Study
Kelly Mercier, Lynne Hernandez, Vanessa Boulanger, Allison Seebald, Suzanne Rossov, and Kelsey Milligan
Journal of Clinical Oncology 37, no. 15_suppl Poster presented at: ASCO 2019. The 55th Annual Meeting of the American Society of Clinical Oncology; 2019 May 31- June 4; Chicago, Illinois. doi:10.1200/JCO.2019.37.15_suppl.e18291
Rare Disease — Desmoid tumors Read -
Poster
European Hematology Association (EHA) · 2019
Quality of Life and Demographics of Patients with Immune Thrombocytopenia (ITP); Data from the Platelet Disorder Support Association (PDSA) Patient Registry
Caroline Kruse, Alexandra Kruse, Nancy Potthast, Vanessa Boulanger, Allison Seebald, Suzanne Rossov and Kelsey Milligan.
Poster presented at: EHA 2019. The 24th Congress of the European Hematology Association; 2019 June 13-16; Amsterdam, The Netherlands. doi:10.1097/01.HS9.0000567492.92876.8b
Rare Disease — Immune thrombocytopenia (ITP) Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2019
The Use of Patient Registry to Better Inform Healthcare Decision Makers and Improve Clinical Outcomes for Patients with Phenylketonuria (PKU)
Bodamer O, Levy H, Blakely E, Brown C, Feldman H, Connolly R, and Moseley K.
Poster presented at: ISPOR 2019 Conference; 2019 May 18-22; New Orleans, LA. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2019.04.1701
Rare Disease — Phenylketonuria (PKU) Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2019
The Use of Patient Reported Registry Data to Improve Health Outcomes for Patients with Opsoclonus Myoclonus Syndrome (OMS)
Michaelis M, Khoury-Dennis C, Boulanger V, Seebald A, Rossov S, Milligan K, and Radtchenko J.
Poster presented at: ISPOR 2019 Conference; 2019 May 18-22; New Orleans, LA. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2019.04.1698
Rare Disease — Opsoclonus myoclonus syndrome (OMS) Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2019
Understanding Disease and Burden in Syngap1-Related Non-Syndromic Intellectual Disability (NSID) Using a Patient Registry Database
Weldon M, Holder J, Rumbaugh G, Smith-Hicks C, Boulanger V, Seebald A, Rossov S, Milligan K, and Radtchenko J
Poster presented at: ISPOR 2019 Conference; 2019 May 18-22; New Orleans, LA. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2019.04.1689
Rare Disease — SYNGAP1-related disorder Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2019
Understanding Real-World Treatment Patterns and Quality of Life in Patients with Pemphigus and Pemphigoid Using a Patient Registry Database
Yale ML, Boulanger V, Seebald A, Rossov S, Milligan K, and Radtchenko J.
Poster presented at: ISPOR 2019 Conference; 2019 May 18-22; New Orleans, LA. Published in Value in Health and ISPOR site. doi:10.1016/j.jval.2019.04.1697
Rare Disease — Pemphigus and pemphigoid Read -
Poster
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) · 2019
Clinical Practice Experience with Tenofovir Alafenamide (TAF) for Treatment of Hepatitis B in the US
Michael Curry, Ho Bae, Douglas Dieterich, Victor Ankoma-Sey, K. Rajender Reddy, Calvin Pan, Hie-Won Hann, Myron Tong, W. Ray Kim, Paul Kwo, Lynn Frazier, Scott Milligan, Janna Radtchenko, and Nezam Afdhal
Poster presented at: ISPOR 2019 Conference; 2019 May 18-22; New Orleans, LA. doi:10.1016/j.jval.2019.04.883
Virology — Hepatitis B (HBV) Read -
Oral Presentation
Asian Pacific Association for the Study of the Liver (APASL) · 2019
Effectiveness and Safety with Tenofovir Alafenamide (TAF) for Hepatitis B in Patients of Asian Race in US Clinical Practice
Michael Curry, Ho Bae, Douglas Dieterich, Victor Ankoma-Sey, K. Rajender Reddy, Calvin Pan, Hie-Won Hann, Myron Tong, W Ray Kim, Paul Kwo, Lynn Frazier, Scott Milligan, Keith Spitz, and Nezam Afdhal.
Oral presented at: APASL 2019. 28th Annual Conference of the Asian Pacific Association for the Study of Liver (APASL); 2019 Feb 20-24; Manila, Philippines. Abstract 627. doi:10.1007/s12072-019-09936-5
Virology — Hepatitis B (HBV) Read -
Poster
The European Association for the Study of the Liver (EASL) · 2019
Effectiveness and Safety with Tenofovir Alafenamide (TAF) for Hepatitis B in US Clinical Practice
Michael Curry, Ho Bae, Douglas Dieterich, Victor Ankoma-Sey, K. Rajender Reddy, Calvin Pan, Hie-Won Hann, Myron Tong, W Ray Kim, Paul Kwo, Lynn Frazier, Scott Milligan, Keith Spitz, and Nezam Afdhal
Poster presented at: The International Liver Congress. 54th Annual Meeting of the European Association for the Study of the Liver; 2019 Apr 10-14; Vienna, Austria. doi:10.1016/S0618-8278(19)30912-0
Virology — Hepatitis B (HBV) Read -
Poster
Academy of Managed Care Pharmacy (AMCP) · 2018
Retrospective, Observational Study of BAX 855 in Clinical Practice in the United States
J. Booth, M. Watt, S. Milligan, and L. Aledort.
AMCP Managed Care & Specialty Pharmacy 2018; 24, No.4-a: D7 Poster presented at: AMCP Managed Care and Specialty Pharmacy Annual Meeting, 2018 Apr 23-26; Boston, MA. doi:10.18553/jmcp.2018.24.4-a.s1
Hematology — Hemophilia A Read -
Oral Presentation
Digestive Disease Week (DDW) · 2018
Behavioral and Clinical Factors and Direct Acting Antiviral (DAA) Effectiveness in HCV/HIV Co-Infection: Clinical Experience from the TRIO Network
Rick Elion, Gregory Huhn, Dushyantha Jayaweera, Keri Althoff, Joseph Eron, Scott Milligan, Anthony Mills, Graeme Moyle, Steven Santiago, Paul Sax, Gene Voskuhl, David Wyles, and Karam Mounzer
Oral presented at: Digestive Disease Week. 2018 June 2-5; Washington DC. doi:10.1016/S0016-5085(18)33670-9
Virology — HIV/HCV co-infection Read -
Poster
The European Association for the Study of the Liver (EASL) · 2018
Behavioral and Clinical Factors and Direct Acting Antiviral Effectiveness in HCV/HIV Co-Infection: Clinical Experience from the TRIO Network
Gregory Huhn, Dushyantha Jayaweera, Keri Althoff, Joseph Eron, Scott Milligan, Anthony Mills, Graeme Moyle, Steven Santiago, Paul Sax, Gene Voskuhl, David Wyles, Karam Mounzer, and Rick Elion
Poster presented at: The International Liver Congress. 53rd Annual Meeting of the European Association for the Study of the Liver; 2018 Apr 11-15; Paris, France. doi:10.1016/S0168-8278(18)30723-2
Virology — HIV/HCV co-infection Read -
Poster
HIV Glasgow · 2018
Clinical Observations of Antiretroviral (ART) Switching in HIV- suppressed Patients After Availability of TAF
Richard Elion, Joseph Eron, Steven Santiago, Paul Sax, Moti Ramgopal, Greg Huhn, Scott Milligan, Keri Althoff, and Jonathan Winston
Poster presented at: HIV Glasgow. 2018 October 28-31; Glasgow, UK; Published in Journal of the International AIDS Society and Glasgow site. Abstract P114. doi:10.1002/jia.2.25187
Virology — HIV Read -
Poster
Digestive Disease Week (DDW) · 2018
Untreated HCV in HIV/HCV Co-Infection: Data from the TRIO Network
Dushwantha Jayaweera, Joseph Eron, Gregory Huhn, Scott Milligan, Anthony Mills, Graeme Moyle, Steven Santiago, Paul Sax, Gene Voskuhl, David Wyles, Karam Mounzer, and Rick Elion
Poster presented at: Digestive Disease Week. 2018 June 2-5; Washington DC. doi:10.1016/S0016-5085(18)33931-3
Virology — HIV/HCV co-infection Read -
Poster
The European Association for the Study of the Liver (EASL) · 2018
Untreated HCV in HIV/HCV Co-Infection: Data from the TRIO Network
Dushyantha Jayaweera, Keri Althoff, Joseph Eron, Gregory Huhn, Scott Milligan, Anthony Mills, Graeme Moyle, Steven Santiago, Paul Sax, Gene Voskuhl, David Wyles, Karam Mounzer, and Rick Elion
Poster presented at: The International Liver Congress. 53rd Annual Meeting of the European Association for the Study of the Liver; 2018 Apr 11-15; Paris, France. doi:10.1016/S0168-8278(18)30735-9
Virology — HIV/HCV co-infection Read
No publications match this filter yet.
Reports & downloads
Take the documentation with you
Feasibility reports, dataset documentation, and company materials: the same files we send during diligence, available without a form.
Dataset documentation
-
Dataset · PDF
Lambda dataset overview
71.8M patients, 35 contributing health systems, note availability and geography.
Updated quarterly · 1 page
-
Dataset · PDF
Omega dataset overview
92.1M patients across 11.7K facilities and 31 data suppliers.
Updated quarterly · 1 page
-
Dataset · PDF
Alpha dataset overview
88.1M patients, 1.9B documented care encounters, payer coverage and geography.
Updated quarterly · 1 page
Newsroom
Announcements and press
-
April 8, 2026 at 10:56 AM
Navidence and Trio Health Announce Strategic Partnership to Deliver Deeper, More Precise Real-World Evidence for Life Sciences
Collaboration Combines Trio Health's Curated EMR Data with Navidence's Computable Operational Definitions to Accelerate Pharma Insights Aurora, CO, April 2026 - Navidence, a technology company helping healthcare and life sciences...
Read the announcement
-
February 25, 2025 at 9:28 AM
Trio Health Appoints Dave Bitner as Chief Commercial Officer
Read the announcement
-
December 7, 2023 at 10:02 AM
Trio Health Appoints Tim Burcham as Chief Technology Officer
LOUISVILLE, CO, December 7, 2023 - Trio Health (Trio), a leading provider of real-time data on real world patients, has announced the appointment of Tim Burcham as its Chief Technology Officer. With over two decades of experience in...
Read the announcement
-
April 26, 2023 at 7:31 AM
Komodo Health Introduces MapEnhance To Accelerate Multidimensional Insights for Healthcare and Life Sciences
https://www.komodohealth.com/news/komodo-health-introduces-mapenhance-to-accelerate-multidimensional-insights-for-healthcare-and-life-sciences
Read the announcement
-
September 20, 2022 at 7:00 AM
Trio Health and Allergy Partners to Form National Allergy and Asthma Patient Registry
https://www.businesswire.com/news/home/20220919005837/en/Trio-Health-and-Allergy-Partners-to-Form-National-Allergy-and-Asthma-Patient-Registry
Read the announcement
-
August 3, 2022 at 11:26 AM
Augmedix - Trio Health - CIIC First of its Kind Real-World Patient Ecosystem - Standardizing Relevant Clinical Data at the Point of Care
https://www.globenewswire.com/news-release/2022/08/03/2491315/0/en/Augmedix-Trio-Health-CIIC-First-of-its-Kind-Real-World-Patient-Ecosystem-Standardizing-Relevant-Clinical-Data-at-the-Point-of-Care.html
Read the announcement
-
May 12, 2022 at 11:27 AM
Trio Health (Trio) and the Consortium of Independent Immunology Clinics (CIIC) announce the launch of the Trio-CIIC HAE Registry
https://www.prnewswire.com/news-releases/trio-health-trio-and-the-consortium-of-independent-immunology-clinics-ciic-announce-the-launch-of-the-trio-ciic-hae-registry-301545559.html?tc=eml_cleartime
Read the announcement
-
October 13, 2021 at 11:27 AM
Trio Health Partners with Datavant to Enable Direct Connectivity to Its Real-World Physician and Patient Ecosystem to Improve Clinical and Patient Outcomes
https://www.globenewswire.com/news-release/2021/10/13/2313298/0/en/Trio-Health-Partners-with-Datavant-to-Enable-Direct-Connectivity-to-Its-Real-World-Physician-and-Patient-Ecosystem-to-Improve-Clinical-and-Patient-Outcomes.html
Read the announcement
-
September 22, 2021 at 10:00 PM
CIIC and Trio Health Introduce the Creation of a Dynamic Rare Disease Patient Registry Platform
https://www.prnewswire.com/news-releases/ciic-and-trio-health-introduce-the-creation-of-a-dynamic-rare-disease-patient-registry-platform-301384088.html
Read the announcement
-
April 29, 2021 at 11:30 AM
Responding to the Patient Voice - Improving Outcomes and Care for People Living with Arthritis
https://www.prnewswire.com/news-releases/responding-to-the-patient-voice--improving-outcomes-and-care-for-people-living-with-arthritis-301280161.html?tc=eml_cleartime
Read the announcement
-
April 1, 2021 at 11:30 AM
American Rheumatology Network (ARN) and Trio Health (Trio) form ARN Clinical Research, a Tech-Enabled Solution to Accelerate Clinical Trials
https://www.prnewswire.com/news-releases/american-rheumatology-network-arn-and-trio-health-trio-form-arn-clinical-research-a-tech-enabled-solution-to-accelerate-clinical-trials-301260974.html
Read the announcement
-
September 29, 2020 at 11:30 AM
Trio Health - Tuning in to the Patient Voice
https://www.prnewswire.com/news-releases/trio-health--tuning-in-to-the-patient-voice-301140084.html
Read the announcement
Looking for something you can't find here?
Tell us the disease area and the question. We will point you to the published work, send the relevant report, and tell you what the record can support.